| Dr David L Mcfadden, MD | |
|
330 Madison St Ste 303, Joliet, IL 60435-6576 | |
| (815) 744-1770 | |
| Not Available |
| Full Name | Dr David L Mcfadden |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 330 Madison St Ste 303, Joliet, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033270533 | NPI | - | NPPES |
| 9908151 | Other | IL | BLUE CROSS BLUE SHIELD |
| 036087527 | Medicaid | IL | |
| 390004585 | Other | IL | PALMETTO RR MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 042008047 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr David L Mcfadden, MD 10660 W 143rd St Ste B, Orland Park, IL 60462-1989 Ph: (708) 349-0055 | Dr David L Mcfadden, MD 330 Madison St Ste 303, Joliet, IL 60435-6576 Ph: (815) 744-1770 |
News Archive
"We need to introduce clinical ethicists in hospitals in the United Kingdom," says a researcher in medical ethics in this week's BMJ.
St. Jude Medical, Inc., a global medical device company, today announced that physicians from the Cedars-Sinai Heart Institute will lead the company's transcatheter aortic valve implantation (TAVI) clinical trial. The study will evaluate the safety and efficacy of the St. Jude Medical transcatheter aortic valve for patients who experience severe aortic stenosis and who may be at an elevated risk for open-heart surgery.
The ability to control whether certain stem cells ultimately become bone cells holds great promise for regenerative medicine and potential therapies aimed at treating metabolic bone diseases. Now, UCLA School of Dentistry professor and leading cancer scientist Dr. Cun-Yu Wang and his research team have made a significant breakthrough in that direction. The scientists have discovered two key epigenetic regulating genes that govern the cell-fate determination of human bone marrow stem cells.
Researchers at the Jefferson Institute of Molecular Medicine were awarded almost $384,000 by the National Institutes of Health to investigate the mechanisms involved in the development of a serious and sometimes fatal disease, known as Nephrogenic Systemic Fibrosis, a rare skin disorder linked to Gadolinium-based contrast agents used in magnetic resonance (MRI and MRA) studies.
Fostering innovation to speed the improvement of health care is the goal of an $8.3 million grant to researchers at Cincinnati Children's Hospital Medical Center.
› Verified 1 days ago
Dr. Gerard Dennis Cerniak, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 208 Timberline Ct., Joliet, IL 60431 Phone: 815-744-7507 | |
Mrs. Beata Agnieszka Kisiel, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2121 Oneida St, Suite 103, Joliet, IL 60435 Phone: 815-741-8480 Fax: 815-741-8497 | |
Divyesh Bhatt, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 330 Madison St Ste 103, Joliet, IL 60435 Phone: 815-514-2975 | |
Rishikesh Morey, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 812 Campus Dr, Joliet, IL 60435 Phone: 815-741-6830 Fax: 815-741-6832 | |
Ahmed Dakka, MD Nephrology Medicare: Medicare Enrolled Practice Location: 2100 Glenwood Ave, Joliet, IL 60435 Phone: 630-873-8889 Fax: 630-456-7138 | |
Punit Vajaria, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2100 Glenwood Ave, Joliet, IL 60435 Phone: 815-725-2121 Fax: 815-741-6303 |